en

BIOTECH BUSINESS Abstract AGEN REINFORCES PATENT POSITION WITH SETTLEMENT OF SUIT AGAINST US COMPANY PRANA'S METAL TECHNOLOGY THEORY FOR ALZHEIMER'S DISEASE SUPPORTED BY FINDINGS METABOLIC ANNOUNCES POSITIVE INTERIM RESULTS FROM PHASE ONE HUMAN TRIALS MEDITECH ANNOUNCES PROGRESS ON PHASE ONE HUMAN CANCER TRIALS AGEN SIGNS DIAGNOSTIC AGREEMENT WITH CORBETT RESEARCH STEM CELL SCIENCES AND AVENTIS PHARMA COLLABORATE IN SEARCH OF ALZHEIMER'S TREATMENT Dendrimer Inventor in Australia to Further Research PROGEN ALLIANCE PARTNER TO CONDUCT INDEPENDENT PHASE 1B CLINICAL TRIAL OF ANTI-CANCER DRUG PI-88 IN TAIWAN INHALIX APPOINTS DR GRAEME WOODROW AS CEO SUMICH ANNOUNCES COLLABORATION WITH POWDERJECT GENETIC ABNORMALITY LINKED TO EPILEPSY PANBIO CLOSER TO FDA APPROVAL FOR GLANDULAR FEVER DIAGNOSTICS BLUE-GREEN ALGAE RESEARCH MEANS EUREKA PRIZE FOR UNSW SCIENTIST SEAWEED: UNSW WINS AGAIN ROTHSCHILD BIOSCIENCE LAUNCHES NEW FUND BIOTA BRANCHES OUT IDT TAKES ON NEW CANCER DRUG START GRANT FOR ALCHEMIA FUNDS FOR VIRAX HIV TRIALS New AusBiotech Members

© Copyright 2001 - AusBiotech
Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16